BioSpace News Archive

KORU Medical Systems today announced that the Company will report first quarter 2023 financial results on Thursday, May 4, 2023.

Enzolytics, Inc. announced that the Company’s representative traveled to Africa to arrange for the delivery of its ITV-1 immunotherapy treatments to African hospitals and to finalize the information to be included on product labels as required by the African regulatory agencies.

Kodiak Sciences Inc. announced today that multiple scientific presentations on its clinical and research pipeline programs will be made at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting, being held from April 23 – 27 in New Orleans, United States.

EDAP TMS SA (Nasdaq: EDAP) (“the Company”) today announced that the Company will be showcasing its Focal One® Robotic High Intensity Focused Ultrasound (HIFU) platform at the upcoming Annual Meeting of the American Urological Association (AUA), the largest gathering of urologists worldwide, which will be held April 28th through May 1st in Chicago, IL.

Solid Biosciences Inc. today announced that Solid management will participate in a fireside chat at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 24, 2023 at 2:00 PM ET.

CymaBay Therapeutics, Inc. today announced that results from the ENHANCE phase 3 global study evaluating seladelpar for primary biliary cholangitis (PBC) have been published in Hepatology.

Ocuphire Pharma, Inc. today announced that it has appointed Rick Rodgers as Interim Chief Executive Officer and President.

Heska Corporation, a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2023 Annual Meeting of Stockholders.

LianBio today announced that China’s National Medical Products Administration (NMPA) has accepted with priority review the New Drug Application (NDA) for mavacamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy (oHCM) in adults.

Cyclo Therapeutics, Inc. today announced that it has closed a private placement of its securities priced at-the-market under Nasdaq rules.